News | March 15, 2023
LifeSigns raises Pre-Series A
A funding to expand operations and provide better patient care
A funding to expand operations and provide better patient care
Proposed combination enhances Pfizer’s position as a leading company in oncology
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Time to combine innovation, access and technology to deliver positive patient outcomes
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
Subscribe To Our Newsletter & Stay Updated
